210115-56-3

Basic information

• Product Name: {3-[(4-butyl-benzylamino)-methyl]-phenyl}-acetic acid methyl ester
• Synonyms: {3-[(4-butyl-benzylamino)-methyl]-phenyl}-acetic acid methyl ester
• CAS NO: 210115-56-3
• Molecular Weight: 325.451
• Mol File: 210115-56-3.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: {3-[(4-butyl-benzylamino)-methyl]-phenyl}-acetic acid methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: {3-[(4-butyl-benzylamino)-methyl]-phenyl}-acetic acid methyl ester(210115-56-3)
• EPA Substance Registry System: {3-[(4-butyl-benzylamino)-methyl]-phenyl}-acetic acid methyl ester(210115-56-3)

Safety Data

• Hazardous Substances Data: 210115-56-3(Hazardous Substances Data)

Upstream product

• 57802-79-6 4-n-butylbenzylamine 
• 142327-44-4 methyl 3-formylphenylacetate 

Downstream Products

• 223490-91-3 (3-{[(4-butyl-benzyl)-(1-methyl-1H-imidazole-4-sulfonyl)-amino]-methyl}-phenyl)-acetic acid methyl ester 

Relevant articles and documents

Methods of treatment using an EP2 selective receptor agonist

The present invention relates to methods of treating pulmonary hypertension, facilitating joint fusion, facilitating tendon and ligament repair, reducing the occurrence of secondary fracture, treating avascular necrosis, facilitating cartilage repair, facilitating bone healing after limb transplantation, facilitating liver regeneration, facilitating wound healing, reducing the occurrence of gastric ulceration, treating hypertension, facilitating the growth of tooth enamel or finger or toe nails, treating glaucoma, treating ocular hypertension, and repairing damage caused by metastatic bone disease using an EP2 selective receptor agonist.